Fetal Therapy Technologies

Name

Fetal Therapy Technologies

Legal name

Fetal Therapy Technologies

Website

https://fetaltherapytechnologies.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Fetal Surgery Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)

akta.pro secondary industry

Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG)

Keywords

• Fetal surgery devices
• Microsurgical instruments
• Surgical port systems
• Fetal therapy equipment
• Minimally invasive surgery

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Revenue generated from the sale of purpose-built microsurgical port devices to fetal surgery centers and hospitals. As a medical device company developing surgical tools, the primary revenue stream is likely from device sales, potentially with associated disposable components and accessories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Fetal Therapy Technologies (FTT) is a microsurgical medical device company that manufactures purpose-built surgical instruments for fetal surgery. Its lead product is a Platform Microsurgical Port System developed in collaboration with the Johns Hopkins Center for Fetal Therapy, designed to enable minimally invasive fetal surgical procedures.

Product overview

Fetal Therapy Technologies is a microsurgical device company developing purpose-built tools for fetal surgery. The company's primary offering is a platform microsurgical port system designed specifically for safe access into the uterus during fetal surgery. This purpose-built device was developed in collaboration with the Johns Hopkins Center for Fetal Therapy to address the limitations of off-label tools borrowed from other medical disciplines, with the goal of reducing complication rates and the risk of preterm birth.

Differentiator

Problem solved

Functional benefit

Products and services

• Platform Microsurgical Port System

Quantifiable outcome

• Reduces preterm birth risk compared to current 40% rate

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Johns Hopkins Center for Fetal TherapycoreStrategic or Co-development PartnerFetal Therapy Technologies has developed their platform microsurgical port system working directly with the Johns Hopkins Center for Fetal Therapy. This collaboration provides clinical validation and domain expertise for the development of purpose-built surgical tools designed specifically for fetal surgery applications. The partnership combines engineering capability with leading clinical expertise in fetal intervention.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Karl Storz: Karl Storz is a leading manufacturer of endoscopes and microsurgical instruments used in minimally invasive surgery. Their portfolio includes specialty instruments for delicate surgical access, directly comparable to FTT's microsurgical port for fetal surgery applications.

Broad incumbents

• Hologic: Hologic is a women's health medical device and diagnostics company with surgical products. They share FTT's focus on women's health clinical applications and the surgical instrument category, though at much greater scale and broader portfolio scope.
• Intuitive Surgical: Intuitive Surgical develops the da Vinci minimally invasive surgical platform. While a much larger incumbent, they operate in the same adjacent space of precision minimally invasive surgical access, serving many of the same hospital departments that perform fetal interventions.
• CooperSurgical: CooperSurgical is a major women's health medical device company with a broad portfolio of surgical and fertility instruments. While they serve women's health broadly rather than specifically fetal surgery, they are a comparable medical device manufacturer in the same clinical customer base.
• Stryker: Stryker is a large medical device company with a significant surgical instruments portfolio including microsurgical tools. Although they serve surgery broadly, their surgical instruments business directly overlaps with FTT's category of microsurgical access devices.
• Medtronic: Medtronic has a substantial surgical and minimally invasive device portfolio. As a broad incumbent in hospital-based surgical devices, they overlap with FTT's customer base and represent potential competitive threat or potential acquirer for this niche technology.
• Ethicon (Johnson & Johnson): Ethicon is a global leader in surgical instruments and supplies, including minimally invasive devices. They serve the same hospital surgical customers as FTT and represent the type of large incumbent that could enter the fetal-specific niche if market traction emerges.

Emerging players

• Natera: Natera focuses on fetal and maternal diagnostics, including non-invasive prenatal testing and pregnancy-related genetic testing. While focused on diagnostics rather than surgery, they share FTT's focus on fetal medicine clinical applications and the same patient/family stakeholders.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/fetal-therapy-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fetal Therapy Technologies